The Cigna Group posted strong Q3 2024 results, yet CI stock is down nearly 20% from its 52-week high. See why this may ...

Ballad Health and Cigna are working to finalize negotiations as a New Year’s Eve deadline looms to keep some of the insurance ...

The Cigna Group on Thursday reported a nearly $740 million profit for the third quarter of 2024, despite an after-tax loss of ...

Cigna surpassed Wall Street estimates for third-quarter profit on Thursday, driven by high demand for biosimilars of a ...

Ballad Health facilities and providers could soon be considered "out-of-network" for those carrying Cigna Healthcare insurance. Negotiations between Ballad and Cigna for the insurance to remain ...

Cigna surpassed quarterly profit estimates on Thursday, driven by strong demand for its specialty drugs and new clients for ...

Cigna (CI) stock gained as company beats Q3 forecasts , driven by Evernorth unit's performance: adjusted income up 5% YoY to $2.1B, revenue at $63.7B. Read more here.

TD Cowen analyst Ryan Langston has maintained their bullish stance on CI stock, giving a Buy rating today. Ryan Langston’s rating is ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Voyager Therapeutics (VYGR – Research Report), Align Tech ...

Health insurance companies are counting on specialty pharmacy to invigorate their finances as other business lines face headwinds.

Cigna reports Q3 sales of $63.7 billion, a 30% YoY increase, driven by Evernorth growth. Adjusted EPS of $7.51 beats estimates. 2024 EPS guidance reaffirmed.

Health insurance company Cigna Group (CI) topped revenue and profit estimates in its third quarter earnings results, while the company reaffirmed its full-year outlook Morning Brief anchors Julie ...